Omar Nadeem, MD
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM (NCT06518551) | Omar Nadeem, MD | 2024-11-01 |
| DARA RVD For High Risk SMM (NCT04775550) | Omar Nadeem, MD | 2021-03-08 |
| Ixazomib + Pomalidomide + Dexamethasone In MM (NCT04094961) | Omar Nadeem, MD | 2019-09-18 |
Track Omar Nadeem, MD automatically
Every clearance here is in the API, with alerts when new ones post.